{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T17:34:24Z","timestamp":1792863264133,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jceh.2022.12.016","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T12:55:30Z","timestamp":1672750530000},"page":"404-413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Anticoagulation for the Treatment of Portal Vein Thrombosis in Cirrhosis: A Systematic Review and Meta-Analysis of Comparative Studies"],"prefix":"10.1016","volume":"13","author":[{"given":"Calvin","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittney","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sammy","family":"Saab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2022.12.016_bib1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.14309\/ajg.0000000000000486","article-title":"ACG clinical guideline: disorders of the hepatic and mesenteric circulation","volume":"115","author":"Simonetto","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.12.016_bib2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1148\/radiol.12112236","article-title":"Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis","volume":"265","author":"Luca","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.jceh.2022.12.016_bib3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/1319-3767.141687","article-title":"Natural course of nonmalignant partial portal vein thrombosis in cirrhotic patients","volume":"20","author":"Girleanu","year":"2014","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.12.016_bib4","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.27546","article-title":"Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study","volume":"61","author":"Nery","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.12.016_bib5","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ajg.2012.452","article-title":"De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes","volume":"108","author":"Maruyama","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.12.016_bib6","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s10620-015-4012-2","article-title":"Direct oral anticoagulants in cirrhosis patients pose similar risks of bleeding when compared to traditional anticoagulation","volume":"61","author":"Intagliata","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2022.12.016_bib7","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.12.016_bib8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American association for the study of liver diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.12.016_bib9","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1053\/j.gastro.2021.08.015","article-title":"AGA clinical practice guideline on the management of coagulation disorders in patients with cirrhosis","volume":"161","author":"O'Shea","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.12.016_bib10","first-page":"311","article-title":"Impact of anticoagulation on outcomes in acute non-cirrhotic and non- malignant portal vein thrombosis: a retrospective observational study","volume":"60","author":"Hall","year":"2013","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.jceh.2022.12.016_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.thromres.2018.12.019","article-title":"Natural history and clinical outcomes in patients with portal vein thrombosis by etiology: a retrospective cohort study","volume":"174","author":"Acuna-Villaorduna","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.jceh.2022.12.016_bib12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MEG.0000000000000482","article-title":"Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis","volume":"28","author":"Chen","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.12.016_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41424-018-0043-2","article-title":"Long-Term outcome of Splanchnic vein thrombosis in cirrhosis","volume":"9","author":"Senzolo","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jceh.2022.12.016_bib14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41395-018-0421-0","article-title":"Clinical impact and safety of anticoagulants for portal vein thrombosis in cirrhosis","volume":"114","author":"Pettinari","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.12.016_bib15","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1478-3231.2012.02785.x","article-title":"Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis","volume":"32","author":"Senzolo","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2022.12.016_bib16","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1007\/s10620-019-05572-z","article-title":"Anticoagulation in\u00a0cirrhosis and portal vein thrombosis is safe and improves prognosis in advanced cirrhosis","volume":"64","author":"Ferreira","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2022.12.016_bib17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cgh.2014.10.010","article-title":"Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis","volume":"13","author":"Berry","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.12.016_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","article-title":"Electronic address eee. EASL clinical practice guidelines: vascular diseases of the liver","volume":"64","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.12.016_bib19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00535-021-01788-x","article-title":"Evidence-based clinical practice guidelines for Liver Cirrhosis 2020","volume":"56","author":"Yoshiji","year":"2021","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jceh.2022.12.016_bib20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jceh.2022.12.016_bib21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.jceh.2022.12.016_bib22","first-page":"1","article-title":"Closing the gap between methodologists and end-users: R as a computational back-end","volume":"49","author":"Wallace","year":"2012","journal-title":"J\u00a0Stat Software"},{"key":"10.1016\/j.jceh.2022.12.016_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A\u00a0basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.jceh.2022.12.016_bib24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jceh.2022.12.016_bib25","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.3","author":"Deeks","year":"2022"},{"key":"10.1016\/j.jceh.2022.12.016_bib26","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jceh.2022.12.016_bib27","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jceh.2022.12.016_bib28","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.jvir.2013.08.018","article-title":"Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up","volume":"24","author":"Cai","year":"2013","journal-title":"J\u00a0Vasc Intervent Radiol"},{"key":"10.1016\/j.jceh.2022.12.016_bib29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3350\/cmh.2014.20.4.384","article-title":"Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis","volume":"20","author":"Chung","year":"2014","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2022.12.016_bib30","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1148\/radiol.2015150369","article-title":"Is post-TIPS anticoagulation therapy necessary in patients with cirrhosis and portal vein thrombosis? A randomized controlled trial","volume":"279","author":"Wang","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.jceh.2022.12.016_bib31","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00508-018-1351-y","article-title":"Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function","volume":"130","author":"Scheiner","year":"2018","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.jceh.2022.12.016_bib32","doi-asserted-by":"crossref","first-page":"E107","DOI":"10.1111\/hepr.12934","article-title":"Antithrombin III for portal vein thrombosis in patients with liver disease: a randomized, double-blind, controlled trial","volume":"48","author":"Hidaka","year":"2018","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jceh.2022.12.016_bib33","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0037-1607049","article-title":"Exploring the outcomes of portal vein thrombosis in the clinical setting of cirrhosis, malignancy, and intra-abdominal infections with and without anticoagulation: a retrospective 5-year study","volume":"27","author":"Sule","year":"2018","journal-title":"Int J Angiol"},{"key":"10.1016\/j.jceh.2022.12.016_bib34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3138\/canlivj.2018-0026","article-title":"HCC complicated by PVT: outcome and the role of anticoagulation therapy","volume":"2","author":"Mahmoudi","year":"2019","journal-title":"Canadian Liver Journal"},{"key":"10.1016\/j.jceh.2022.12.016_bib35","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/MEG.0000000000001846","article-title":"Efficacy and safety study of direct-acting oral anticoagulants for the treatment of chronic portal vein thrombosis in patients with liver cirrhosis","volume":"32","author":"Ai","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.12.016_bib36","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000228","article-title":"Efficacy and safety of nadroparin calcium-warfarin Sequential anticoagulation in portal vein thrombosis in cirrhotic patients: a randomized controlled trial","volume":"11","author":"Zhou","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jceh.2022.12.016_bib37","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.14309\/ajg.0000000000001194","article-title":"Anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis: a prospective observational study","volume":"116","author":"Lv","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.12.016_bib38","doi-asserted-by":"crossref","first-page":"374","DOI":"10.15403\/jgld-3392","article-title":"Anticoagulation therapy for portal vein thrombosis in patients with cirrhosis in a tertiary center experience","volume":"30","author":"Florescu","year":"2021","journal-title":"J\u00a0Gastrointestin Liver Dis"},{"key":"10.1016\/j.jceh.2022.12.016_bib39","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1007\/s10620-020-06695-4","article-title":"Safety, efficacy, and long-term outcomes of anticoagulation in cirrhotic portal vein thrombosis","volume":"66","author":"Naymagon","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2022.12.016_bib40","article-title":"Comparison of non-tumoral portal vein thrombosis management in cirrhotic patients: TIPS versus anticoagulation versus No treatment","volume":"10","author":"Zhan","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jceh.2022.12.016_bib41","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1111\/jth.15472","article-title":"Therapeutic anticoagulation after liver transplantation is not useful among patients with pre-transplant Yerdel-grade I\/II portal vein thrombosis: a two-center retrospective study","volume":"19","author":"Bos","year":"2021","journal-title":"J\u00a0Thromb Haemostasis"},{"key":"10.1016\/j.jceh.2022.12.016_bib42","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jceh.2021.11.003","article-title":"Portal vein thrombosis in cirrhosis","volume":"12","author":"Shukla","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.12.016_bib43","doi-asserted-by":"crossref","DOI":"10.1177\/10760296221104797","article-title":"The efficacy and safety of anticoagulants in the treatment of cirrhotic portal vein thrombosis: a systematic review and meta-analysis","volume":"28","author":"Zhang","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jceh.2022.12.016_bib44","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1007\/s12072-021-10233-3","article-title":"A\u00a0systematic review and meta-analysis of anticoagulation therapy for portal vein thrombosis in patients with cirrhosis: to treat or not to treat?","volume":"15","author":"Dong","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2022.12.016_bib45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.dld.2021.07.039","article-title":"Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: a systematic review and meta-analysis","volume":"54","author":"Koh","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jceh.2022.12.016_bib46","first-page":"104","article-title":"Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis: a systematic review and meta-analysis","volume":"34","author":"Ghazaleh","year":"2021","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.jceh.2022.12.016_bib47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejim.2014.12.002","article-title":"Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies","volume":"26","author":"Qi","year":"2015","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jceh.2022.12.016_bib48","article-title":"Usage of direct acting oral anticoagulants in cirrhotic and non-cirrhotic portal vein thrombosis: a systematic review","volume":"13","author":"Gupta","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jceh.2022.12.016_bib49","first-page":"521","article-title":"Treatment response and bleeding events associated with anticoagulant therapy of portal vein thrombosis in cirrhotic patients: systematic review and meta-analysis","volume":"33","author":"Mohan","year":"2020","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.jceh.2022.12.016_bib50","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1053\/j.gastro.2017.04.042","article-title":"Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis","volume":"153","author":"Loffredo","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.12.016_bib51","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1007\/s10620-019-05572-z","article-title":"Anticoagulation in cirrhosis and portal vein thrombosis is safe and improves prognosis in advanced cirrhosis","volume":"64","author":"Noronha Ferreira","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2022.12.016_bib52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3138\/canlivj.2018-0026","article-title":"HCC complicated by PVT: outcome and the role of anticoagulation therapy","volume":"2","author":"Mahmoudi","year":"2019","journal-title":"Can Liver J"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322005631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322005631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:10:19Z","timestamp":1760854219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688322005631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0973688322005631"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2022.12.016","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulation for the Treatment of Portal Vein Thrombosis in Cirrhosis: A Systematic Review and Meta-Analysis of Comparative Studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2022.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}